Log in
Enquire now
‌

US Patent 11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto

Patent 11311532 was granted and assigned to Neurocrine Biosciences on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Neurocrine Biosciences
Neurocrine Biosciences
Current Assignee
Neurocrine Biosciences
Neurocrine Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11311532
Date of Patent
April 26, 2022
Patent Application Number
17074383
Date Filed
October 19, 2020
Patent Citations
‌
US Patent 10874648 Methods for the administration of certain VMAT2 inhibitors
‌
US Patent 10906902 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)
‌
US Patent 10906903 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)
‌
US Patent 10912771 Methods for the administration of certain VMAT2 inhibitors
‌
US Patent 10919892 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)
‌
US Patent 10952997 Methods for the administration of certain VMAT2 inhibitors
‌
US Patent 10993941 Methods for the administration of certain VMAT2 inhibitors
‌
US Patent 11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto
...
Patent Citations Received
‌
US Patent 11654142 Methods for the administration of certain VMAT2 inhibitors
0
Patent Primary Examiner
‌
Robert A Wax
CPC Code
‌
A61K 9/48
‌
A61K 47/02
‌
A61K 47/12
‌
A61K 47/26
‌
A61K 47/36
‌
A61K 47/38
‌
A61K 9/0053
‌
A61K 31/4745

Solid pharmaceutical compositions with high drug loading are provided. A formulation useful for the solid pharmaceutical composition includes valbenazine, or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, isomalt, hydroxypropyl methylcellulose, partially pregelatinized maize starch, and magnesium stearate.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.